The Long Run with Luke Timmerman
A podcast by Timmerman Report
173 Episodio
-
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
Pubblicato: 07/06/2022 -
Ep114: Chris Gibson on Industrializing Drug Discovery
Pubblicato: 23/05/2022 -
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs
Pubblicato: 09/05/2022 -
Ep112: Bernat Olle on Microbiome Therapeutics
Pubblicato: 18/04/2022 -
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
Pubblicato: 14/03/2022 -
Ep110: Michele Andrasik on Making Clinical Trials More Diverse
Pubblicato: 01/03/2022 -
Ep109: Derrell Porter on Cell Therapy Commercialization
Pubblicato: 15/02/2022 -
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
Pubblicato: 31/01/2022 -
Ep107: Bassil Dahiyat on Antibody Engineering & Company Building
Pubblicato: 11/01/2022 -
Ep106: Vineeta Agarwala on Health Data & VC Investing
Pubblicato: 20/12/2021 -
Ep105: Nello Mainolfi on Targeted Protein Degraders
Pubblicato: 06/12/2021 -
Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity
Pubblicato: 01/12/2021 -
Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer
Pubblicato: 23/11/2021 -
Ep102: David Baltimore Reflects on a Life in Science
Pubblicato: 08/11/2021 -
Ep101: Tony Kulesa on Fostering Founder-Led Biotechs
Pubblicato: 26/10/2021 -
Ep100: Christian Henry on Long Read DNA Sequencing
Pubblicato: 13/10/2021 -
Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations
Pubblicato: 27/09/2021 -
Ep98: Mara Aspinall on Diagnostics and COVID-19
Pubblicato: 13/09/2021 -
Ep97: John Evans on Base Edited Therapeutics
Pubblicato: 07/09/2021 -
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Pubblicato: 09/08/2021
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
